It allows continued monitoring of the benefit/risk balance of the medicinal product
Effect of Drugs Used in Pharmacotherapy of Type 2 Diabetes on Bone Density and Risk of Bone Fractures
Patients using these devices can see measurable improvements in oxygen saturation, apnea events, and overall sleep quality, especially when paired with weight loss drugs for sleep apnea therapies
In individuals with certain genetic variations, such as mutations in the cystathionine -synthase (CBS) gene, the need for riboflavin may be higher to effectively manage their sulfur metabolism
ATTAIN 1 clinical trial demonstrates that individuals with overweight and obesity who used the highest dose of orforglipron (36 mg) lost 12.4% of body weight after 72 weeks
Takeda acquired ex-China rights to fruquintinib, a VEGFR-1, VEGFR-2 and VEGFR-3 inhibitor, from Hutchmed China Ltd